TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
88.58
-1.06 (-1.18%)
Aug 14, 2026, 4:00 PM EDT - Market closed
TransMedics Group Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, TransMedics Group stock has a consensus rating of "Buy" and an average price target of $97.3. The average 1-year stock price forecast is 9.84% higher than the current stock price, while the lowest is $65 (-26.62%) and the highest is $125 (+41.12%).
Price Target: $97.3 (+9.84%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 6 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $65 | Hold | Maintains | $65 | -26.62% | Aug 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $95 | Buy | Maintains | $95 | +7.25% | Aug 12, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $73 | Hold | Maintains | $73 | -17.59% | Aug 7, 2026 |
| UBS | UBS | Hold Reiterates $80 → $77 | Hold | Reiterates | $80 → $77 | -13.07% | Aug 5, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $120 → $122 | Buy | Maintains | $120 → $122 | +37.73% | Aug 5, 2026 |
Financial Forecast
Revenue This Year
741.71M
from 605.49M
Increased by 22.50%
Revenue Next Year
874.73M
from 741.71M
Increased by 17.93%
EPS This Year
1.56
from 2.63
Decreased by -40.65%
EPS Next Year
2.31
from 1.56
Increased by 47.88%
EPS and Forward PE are based on non-GAAP adjusted numbers.